ASML vs MNPR · P/E 57, $665.37B cap vs $431.4M cap
ASML Holding NV ADR (ASML) versus Monopar Therapeutics Inc (MNPR) — a side-by-side from cached financials, not a winner call.
ASML Holding NV ADR (ASML) is a semiconductor equipment & materials company listed on US.
Monopar Therapeutics Inc (MNPR) is a biotechnology company listed on US.
ASML does not have a complete income-statement cache yet.
Latest reported MNPR revenue for 2024-12-31 was $0. Net income was -$15.6M. MNPR currently screens at market cap $431.4M.
ASML currently screens at market cap $665.37B and trailing P/E 57.5. MNPR currently screens at market cap $431.4M.
Not investment advice. Open the ASML and MNPR stock pages for the full models.
Not investment advice.